Fig. 1 | Scientific Reports

Fig. 1

From: lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway

Fig. 1

Clinical significance of lnc-CHAF1B-2. (A) The pivotal role of lnc-CHAF1B-2 in various cancers. (B) Differential expression of lnc-CHAF1B-2 between the cancer cohort and the control group. (C–J) Association of lnc-CHAF1B-2 expression with sex, age, ethnicity, pathological type, clinical stage, depth of tumour invasion, presence of lymph node metastasis, and distant metastasis in cancer patients. (K) lnc-CHAF1B-2 proficiently differentiated between cancerous and noncancerous tissues in gastric cancer. (L–M) Survival analysis showing that lnc-CHAF1B-2 correlated negatively with both the overall and disease-specific survival rates of patients. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Back to article page